✦ LIBER ✦

A randomized, double-blind, placebo-controlled 16 week study of the H3 receptor antagonist GSK239512 in subjects with mild-to-moderate Alzheimer's disease (AD)

✍ Scribed by Grove, Richard; Horrigan, Joseph; Harrington, Conn; Beresford, Isabel; Mahler, Andreas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 24-week, double-blind, placebo-control

✍ X. A. Alvarez; R. Cacabelos; M. Laredo; V. Couceiro; C. Sampedro; M. Varela; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Saffron in the treatment of patients wit

✍ S. Akhondzadeh; M. Shafiee Sabet; M. H. Harirchian; M. Togha; H. Cheraghmakani; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

A Randomized, Double-blind, Placebo-Cont

📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 231 KB

Study of the ketogenic agent AC-1202 in

✍ Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; La 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 640 KB

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONT

✍ Cummings, Jeffrey; Cho, William; Ward, Michael; Friesenhahn, Michel; Brunstein, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A long-term, double-blind, placebo-contr

✍ L. Amaducci; K. Maurer; B. Winblad; R. Dom; R. Bullock; L. Bonura; A. Battaglia; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 291 KB